drugset / Trial / NCT01557335

A Study to Evaluate Platlet Aggregation of Clopidogrel, EC Aspirin 81 mg, EC Omeprazole 40 mg Compare to PA32540

NCT01557335

Phase 1 Completed 30 enrolled POZEN
RandomizedCrossoverOpen-labelTreatment

Summary

This study is designed to provide data on platelet aggregation of PA32540 plus clopidogrel dosed separately compared to EC aspirin 81 mg plus EC omeprazole 40 mg plus clopidogrel dosed concomitantly.

Timeline

Start
2010-11
Primary completion
2011-02
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 81 mg
Subject Clopidogrel Small molecule 75 mg
Comparator Omeprazole Other / unclassified 40 mg
Subject PA32540 Unknown